Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
27
APVO Quote, Financials, Valuation and Earnings
Last price:
$4.36
Seasonality move
:
-31.63%
Day range:
$4.23 - $4.73
52-week range:
$3.65 - $399.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
0.49x
Volume:
93K
Avg. volume:
354.7K
1-year change:
-98.55%
Market cap:
$2.2M
Revenue:
--
EPS (TTM):
-$3,598.31
Aptevo Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
APVO
Aptevo Therapeutics
|
11/14/2023 | 10-Q | 10-Q filing on 11/14/2023 | View Form |
|
APVO
Aptevo Therapeutics
|
08/10/2023 | 10-Q | 10-Q filing on 08/10/2023 | View Form |
|
APVO
Aptevo Therapeutics
|
05/11/2023 | 10-Q | 10-Q filing on 05/11/2023 | View Form |
|
APVO
Aptevo Therapeutics
|
11/10/2022 | 10-Q | 10-Q filing on 11/10/2022 | View Form |
|
APVO
Aptevo Therapeutics
|
08/11/2022 | 10-Q | 10-Q filing on 08/11/2022 | View Form |
|
APVO
Aptevo Therapeutics
|
05/12/2022 | 10-Q | 10-Q filing on 05/12/2022 | View Form |
|
APVO
Aptevo Therapeutics
|
11/12/2021 | 10-Q | 10-Q filing on 11/12/2021 | View Form |
|
APVO
Aptevo Therapeutics
|
08/12/2021 | 10-Q | 10-Q filing on 08/12/2021 | View Form |
|
APVO
Aptevo Therapeutics
|
05/11/2021 | 10-Q | 10-Q filing on 05/11/2021 | View Form |
|
APVO
Aptevo Therapeutics
|
11/10/2020 | 10-Q | 10-Q filing on 11/10/2020 | View Form |
|
APVO
Aptevo Therapeutics
|
08/14/2020 | 10-Q | 10-Q filing on 08/14/2020 | View Form |
|
APVO
Aptevo Therapeutics
|
05/13/2020 | 10-Q | 10-Q filing on 05/13/2020 | View Form |
|
APVO
Aptevo Therapeutics
|
03/25/2020 | 10-K | 10-K filing on 03/25/2020 | View Form |
|
APVO
Aptevo Therapeutics
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
APVO
Aptevo Therapeutics
|
08/09/2019 | 10-Q | 10-Q filing on 08/09/2019 | View Form |
|
APVO
Aptevo Therapeutics
|
05/09/2019 | 10-Q | 10-Q filing on 05/09/2019 | View Form |
|
APVO
Aptevo Therapeutics
|
03/18/2019 | 10-K | 10-K filing on 03/18/2019 | View Form |
|
APVO
Aptevo Therapeutics
|
11/14/2018 | 10-Q | 10-Q filing on 11/14/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
08/09/2018 | 10-Q | 10-Q filing on 08/09/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
07/27/2018 | 10-K | 10-K filing on 07/27/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
03/13/2018 | 10-K | 10-K filing on 03/13/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
11/13/2017 | 10-Q | 10-Q filing on 11/13/2017 | View Form |
|
APVO
Aptevo Therapeutics
|
08/10/2017 | 10-Q | 10-Q filing on 08/10/2017 | View Form |
|
APVO
Aptevo Therapeutics
|
05/12/2017 | 10-Q | 10-Q filing on 05/12/2017 | View Form |
|
APVO
Aptevo Therapeutics
|
03/31/2017 | 10-K | 10-K filing on 03/31/2017 | View Form |
|
APVO
Aptevo Therapeutics
|
11/14/2016 | 10-Q | 10-Q filing on 11/14/2016 | View Form |
|
APVO
Aptevo Therapeutics
|
09/22/2016 | 10-Q | 10-Q filing on 09/22/2016 | View Form |
|
APVO
Aptevo Therapeutics
|
08/25/2016 | 10-Q | 10-Q filing on 08/25/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
